AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

PARSONS CAPITAL MANAGEMENT INC/RI's Holding History (CIK: 0001018674)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 21,645 Value ($000) $261 Avg Close $13.58 Range $11.69 - $16.96
Q3 2025
Shares 21,645 Value ($000) $294 Avg Close $9.41 Range $5.97 - $15.14
Q2 2025
Shares 21,645 Value ($000) $139 Avg Close $4.86 Range $3.11 - $6.70
Q1 2025
Shares 21,645 Value ($000) $77 Avg Close $3.56 Range $2.60 - $4.18
Q4 2024
Shares 21,645 Value ($000) $82 Avg Close $4.71 Range $2.91 - $7.27
Q3 2024
Shares 21,945 Value ($000) $71 Avg Close $2.25 Range $1.62 - $3.33
Q2 2024
Shares 21,945 Value ($000) $42 Avg Close $1.94 Range $1.57 - $2.89
Q1 2024
Shares 21,945 Value ($000) $62 Avg Close $13.08 Range $2.67 - $19.95
Q4 2023
Shares 21,945 Value ($000) $323 Avg Close $15.33 Range $11.82 - $18.88
Q3 2023
Shares 21,945 Value ($000) $402 Avg Close $21.15 Range $17.80 - $25.48
Q2 2023
Shares 21,945 Value ($000) $473 Avg Close $27.01 Range $20.79 - $31.77
Q1 2023
Shares 21,945 Value ($000) $644 Avg Close $34.74 Range $26.64 - $41.93
Q4 2022
Shares 27,145 Value ($000) $1,003 Avg Close $35.49 Range $28.13 - $39.77
Q3 2022
Shares 16,865 Value ($000) $475 Avg Close $24.95 Range $15.80 - $32.80